Skip to content

The Therapeutics Effects of Yoga in Individuals With Parkinson's Disease

The Therapeutic Effects of Yoga in Individuals With Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00312559
Enrollment
18
Registered
2006-04-10
Start date
2006-02-28
Completion date
2007-03-31
Last updated
2007-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Parkinson's Disease

Brief summary

To determine if yoga is beneficial in improving physical function quality of life and medical status in people with Parkinson's disease

Detailed description

This pilot study is a randomized controlled study of 20-30 individuals with Parkinson's disease will have a control group with no training and a research group with yoga training. The control group will have the opportunity to attend yoga training of the same intensity after the study is completed. The effects of yoga will not be on the control group. Data on physical function will be derived from assessments including strength, balance, flexibility, ROM. gait, posture and functional analysis performed in the Georgia Holland Cardiopulmonary and Neuromuscular Research Lab. Questionnaires related to quality of life, depression and falls will determine psychological impact or yoga training. Vital signs, pulmonary function tests and blood draws will be done in the General Clinical research Center (GCRC) and protein analysis will be done in the diabetes research lab.

Interventions

BEHAVIORALYoga Training

Sponsors

University of Kansas
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Parkinson's Disease * Stage 1-3 Hoehn & Yahr

Exclusion criteria

* Decline in immune function * 6 month joint surgery * spinal fusions * decline in mental status measured by Folstein Mini Mental Status Exam

Design outcomes

Primary

MeasureTime frame
Pulmonary function test, serum protein levels BP, HR, RR, strength testing using microFET, flexibility and range of motion testing using goniometer, balance/posture gait optitrk system, Berg balance scale

Secondary

MeasureTime frame
Unified Parkinson's Disease Rating Scale
Hoehn & Yahr Classification Scale

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026